Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute myeloid leukemia with minimal differentiation. A multiple parameter study

P L Cohen1, J D Hoyer, P J Kurtin

  • 1Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.

American Journal of Clinical Pathology
|January 14, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

European LeukemiaNet-defined primary refractory acute myeloid leukemia: the value of allogeneic hematopoietic stem cell transplant and overall response.

Blood cancer journal·2022
Same author

Systemic amyloidosis from A (AA) to T (ATTR): a review.

Journal of internal medicine·2020
Same author

Extramedullary hematopoiesis in the absence of myeloproliferative neoplasm: Mayo Clinic case series of 309 patients.

Blood cancer journal·2018
Same author

Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients.

Blood cancer journal·2017
Same author

Prognostic significance of ASXL1 mutation types and allele burden in myelofibrosis.

Leukemia·2017
Same journal

Communication patterns among surgical pathologists: a retrospective review of ideal strategies in a tertiary care setting.

American journal of clinical pathology·2026
Same journal

Invasive urothelial carcinoma in association with surface low-grade papillary urothelial carcinoma: clinical and pathologic insights from a rare entity.

American journal of clinical pathology·2026
Same journal

CEACAM1 expression by immunohistochemistry in B-cell lymphomas and plasma cell myeloma.

American journal of clinical pathology·2026
Same journal

Comprehensive multicriteria life cycle assessment of biopsy processing in a surgical pathology department.

American journal of clinical pathology·2026
Same journal

Prognostic significance of Myb protein and its downstream target genes in lacrimal gland adenoid cystic carcinoma.

American journal of clinical pathology·2026
Same journal

Mismatch repair protein "nonclassic expression loss" pattern in colorectal cancer: an important staining pattern that is not well understood.

American journal of clinical pathology·2026
See all related articles

Acute myeloid leukemia with minimal differentiation (AML-M0) affects older males and shows specific immunophenotypes. Bone marrow transplantation may offer better outcomes for AML-M0 patients resistant to chemotherapy.

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Acute myeloid leukemia with minimal differentiation (AML-M0) is a rare subtype requiring further characterization.
  • Limited large-scale studies exist for AML-M0, hindering understanding of its clinical and pathological landscape.

Purpose of the Study:

  • To comprehensively analyze the clinical, pathological, and cytogenetic features of AML-M0.
  • To identify prognostic factors and potential therapeutic strategies for AML-M0.

Main Methods:

  • Retrospective review of 17 AML-M0 patients.
  • Analysis included morphology, cytochemistry, immunophenotyping (CD13, CD33, CD34, HLA-DR, lymphoid antigens, TdT), and cytogenetics.
  • Clinical data and treatment outcomes were assessed.

Related Experiment Videos

Main Results:

  • The study identified a predominantly male patient population (median age 62 years).
  • Leukemic blasts were negative for myeloperoxidase and esterase but positive for CD13, CD33, CD34, and HLA-DR.
  • Common cytogenetic findings included monosomy 7 and trisomy 13; AML-M0 showed resistance to chemotherapy, with bone marrow transplantation offering improved outcomes.

Conclusions:

  • AML-M0 is a distinct entity primarily affecting older males, characterized by specific immunophenotypic markers.
  • Cytogenetic abnormalities, particularly involving chromosomes 7 and 13, are frequent in AML-M0.
  • While chemotherapy resistance is noted, allogeneic stem cell transplantation may improve survival for eligible AML-M0 patients.